APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Drug-Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-Drug-Eluting Devices Industry Growth and Trends Forecast to 2032

26 December 2025101 pages

Choose your research edition.

Industry ResearchNon-Drug-Eluting Devices Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Drug-Eluting Devices Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Non-Drug-Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Drug-Eluting Devices Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Drug-Eluting Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non-Drug-Eluting Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Drug-Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-Drug-Eluting Devices include Teleflex Incorporated, Johnson & Johnson, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew plc., Peter Surgical and Integra Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-Drug-Eluting Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-Drug-Eluting Devices market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-Drug-Eluting Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-Drug-Eluting Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Non-Drug-Eluting Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-Drug-Eluting Devices Market by Company

Teleflex Incorporated

Johnson & Johnson

Medtronic

Boston Scientific Corporation

B. Braun Melsungen AG

Stryker Corporation

Smith & Nephew plc.

Peter Surgical

Integra Lifesciences

DemeTECH Corporation

ConMed Corporation

Non-Drug-Eluting Devices Segment by Type

Implants

Sutures

Non-Drug-Eluting Devices Segment by Application

Hospital

Ambulatory Surgical Centers

Non-Drug-Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Drug-Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Drug-Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Drug-Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Non-Drug-Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Implants Table 2. Major Company of Sutures Table 3. Global Non-Drug-Eluting Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 5. Global Non-Drug-Eluting Devices Sales Market Share in Volume by Type (2021-2026) Table 6. Global Non-Drug-Eluting Devices Sales by Type (2021-2026) & (US$ Million) Table 7. Global Non-Drug-Eluting Devices Sales Market Share in Value by Type (2021-2026) Table 8. Global Non-Drug-Eluting Devices Price by Type (2021-2026) & (US$/Unit) Table 9. Global Non-Drug-Eluting Devices Sales by Type (2027-2032) & (K Units) Table 10. Global Non-Drug-Eluting Devices Sales Market Share in Volume by Type (2027-2032) Table 11. Global Non-Drug-Eluting Devices Sales by Type (2027-2032) & (US$ Million) Table 12. Global Non-Drug-Eluting Devices Sales Market Share in Value by Type (2027-2032) Table 13. Global Non-Drug-Eluting Devices Price by Type (2027-2032) & (US$/Unit) Table 14. North America Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 15. North America Non-Drug-Eluting Devices Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 17. Europe Non-Drug-Eluting Devices Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Non-Drug-Eluting Devices Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 21. Latin America Non-Drug-Eluting Devices Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Non-Drug-Eluting Devices Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Non-Drug-Eluting Devices Sales by Type (2021-2026) & (US$ Million) Table 24. Non-Drug-Eluting Devices Industry Trends Table 25. Non-Drug-Eluting Devices Industry Drivers Table 26. Non-Drug-Eluting Devices Industry Opportunities and Challenges Table 27. Non-Drug-Eluting Devices Industry Restraints Table 28. Global Non-Drug-Eluting Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Non-Drug-Eluting Devices Revenue Market Share by Company (2021-2026) Table 30. Global Non-Drug-Eluting Devices Sales by Company (2021-2026) & (K Units) Table 31. Global Non-Drug-Eluting Devices Sales Share by Company (2021-2026) Table 32. Global Non-Drug-Eluting Devices Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Non-Drug-Eluting Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Non-Drug-Eluting Devices Major Company Production Sites and Headquarters Table 35. Global Non-Drug-Eluting Devices Company, Product Type & Application Table 36. Global Non-Drug-Eluting Devices Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Non-Drug-Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Non-Drug-Eluting Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Non-Drug-Eluting Devices Sales by Region (2021-2026) & (K Units) Table 41. Global Non-Drug-Eluting Devices Sales Market Share in Volume by Region (2021-2026) Table 42. Global Non-Drug-Eluting Devices Sales by Region (2021-2026) & (US$ Million) Table 43. Global Non-Drug-Eluting Devices Sales Market Share in Value by Region (2021-2026) Table 44. Global Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Non-Drug-Eluting Devices Sales by Region (2027-2032) & (K Units) Table 46. Global Non-Drug-Eluting Devices Sales Market Share in Volume by Region (2027-2032) Table 47. Global Non-Drug-Eluting Devices Sales by Region (2027-2032) & (US$ Million) Table 48. Global Non-Drug-Eluting Devices Sales Market Share in Value by Region (2027-2032) Table 49. Global Non-Drug-Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Non-Drug-Eluting Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 52. Global Non-Drug-Eluting Devices Sales Market Share in Volume by Application (2021-2026) Table 53. Global Non-Drug-Eluting Devices Sales by Application (2021-2026) & (US$ Million) Table 54. Global Non-Drug-Eluting Devices Sales Market Share in Value by Application (2021-2026) Table 55. Global Non-Drug-Eluting Devices Price by Application (2021-2026) & (US$/Unit) Table 56. Global Non-Drug-Eluting Devices Sales by Application (2027-2032) & (K Units) Table 57. Global Non-Drug-Eluting Devices Sales Market Share in Volume by Application (2027-2032) Table 58. Global Non-Drug-Eluting Devices Sales by Application (2027-2032) & (US$ Million) Table 59. Global Non-Drug-Eluting Devices Sales Market Share in Value by Application (2027-2032) Table 60. Global Non-Drug-Eluting Devices Price by Application (2027-2032) & (US$/Unit) Table 61. North America Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 62. North America Non-Drug-Eluting Devices Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 64. Europe Non-Drug-Eluting Devices Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Non-Drug-Eluting Devices Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 68. Latin America Non-Drug-Eluting Devices Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Non-Drug-Eluting Devices Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Non-Drug-Eluting Devices Sales by Application (2021-2026) & (US$ Million) Table 71. Teleflex Incorporated Company Information Table 72. Teleflex Incorporated Business Overview Table 73. Teleflex Incorporated Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio Table 75. Teleflex Incorporated Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Medtronic Company Information Table 82. Medtronic Business Overview Table 83. Medtronic Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Medtronic Non-Drug-Eluting Devices Product Portfolio Table 85. Medtronic Recent Development Table 86. Boston Scientific Corporation Company Information Table 87. Boston Scientific Corporation Business Overview Table 88. Boston Scientific Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio Table 90. Boston Scientific Corporation Recent Development Table 91. B. Braun Melsungen AG Company Information Table 92. B. Braun Melsungen AG Business Overview Table 93. B. Braun Melsungen AG Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio Table 95. B. Braun Melsungen AG Recent Development Table 96. Stryker Corporation Company Information Table 97. Stryker Corporation Business Overview Table 98. Stryker Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Stryker Corporation Non-Drug-Eluting Devices Product Portfolio Table 100. Stryker Corporation Recent Development Table 101. Smith & Nephew plc. Company Information Table 102. Smith & Nephew plc. Business Overview Table 103. Smith & Nephew plc. Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio Table 105. Smith & Nephew plc. Recent Development Table 106. Peter Surgical Company Information Table 107. Peter Surgical Business Overview Table 108. Peter Surgical Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Peter Surgical Non-Drug-Eluting Devices Product Portfolio Table 110. Peter Surgical Recent Development Table 111. Integra Lifesciences Company Information Table 112. Integra Lifesciences Business Overview Table 113. Integra Lifesciences Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio Table 115. Integra Lifesciences Recent Development Table 116. DemeTECH Corporation Company Information Table 117. DemeTECH Corporation Business Overview Table 118. DemeTECH Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio Table 120. DemeTECH Corporation Recent Development Table 121. ConMed Corporation Company Information Table 122. ConMed Corporation Business Overview Table 123. ConMed Corporation Non-Drug-Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. ConMed Corporation Non-Drug-Eluting Devices Product Portfolio Table 125. ConMed Corporation Recent Development Table 126. North America Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 128. North America Non-Drug-Eluting Devices Sales Market Share by Country (2021-2026) Table 129. North America Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Non-Drug-Eluting Devices Sales Market Share Forecast by Country (2027-2032) Table 131. North America Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Non-Drug-Eluting Devices Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Non-Drug-Eluting Devices Market Share by Country (2021-2026) Table 134. North America Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Non-Drug-Eluting Devices Market Share Forecast by Country (2027-2032) Table 136. Europe Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 138. Europe Non-Drug-Eluting Devices Sales Market Share by Country (2021-2026) Table 139. Europe Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Non-Drug-Eluting Devices Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Non-Drug-Eluting Devices Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Non-Drug-Eluting Devices Market Share by Country (2021-2026) Table 144. Europe Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Non-Drug-Eluting Devices Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Non-Drug-Eluting Devices Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Non-Drug-Eluting Devices Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Non-Drug-Eluting Devices Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Non-Drug-Eluting Devices Market Share by Country (2021-2026) Table 154. Asia-Pacific Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Non-Drug-Eluting Devices Market Share Forecast by Country (2027-2032) Table 156. Latin America Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 158. Latin America Non-Drug-Eluting Devices Sales Market Share by Country (2021-2026) Table 159. Latin America Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Non-Drug-Eluting Devices Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Non-Drug-Eluting Devices Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Non-Drug-Eluting Devices Market Share by Country (2021-2026) Table 164. Latin America Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Non-Drug-Eluting Devices Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Non-Drug-Eluting Devices Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Non-Drug-Eluting Devices Market Share by Country (2021-2026) Table 174. Middle East and Africa Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Non-Drug-Eluting Devices Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Non-Drug-Eluting Devices Distributors List Table 179. Non-Drug-Eluting Devices Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Non-Drug-Eluting Devices Image Figure 2. Global Non-Drug-Eluting Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Drug-Eluting Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Drug-Eluting Devices Sales (2021-2032) & (K Units) Figure 5. Implants Image Figure 6. Global Implants Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sutures Image Figure 8. Global Sutures Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Non-Drug-Eluting Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Non-Drug-Eluting Devices Market Share by Type 2025 VS 2032 Figure 11. North America Non-Drug-Eluting Devices Sales Market Share in Volume by Type in 2025 Figure 12. North America Non-Drug-Eluting Devices Sales Market Share in Value by Type in 2025 Figure 13. Europe Non-Drug-Eluting Devices Sales Market Share in Volume by Type in 2025 Figure 14. Europe Non-Drug-Eluting Devices Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Non-Drug-Eluting Devices Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Non-Drug-Eluting Devices Sales Market Share in Value by Type in 2025 Figure 17. Latin America Non-Drug-Eluting Devices Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Non-Drug-Eluting Devices Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Non-Drug-Eluting Devices Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Ambulatory Surgical Centers Image Figure 26. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Non-Drug-Eluting Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Non-Drug-Eluting Devices Market Share by Application 2025 VS 2032 Figure 29. North America Non-Drug-Eluting Devices Sales Market Share in Volume by Application in 2025 Figure 30. North America Non-Drug-Eluting Devices Sales Market Share in Value by Application in 2025 Figure 31. Europe Non-Drug-Eluting Devices Sales Market Share in Volume by Application in 2025 Figure 32. Europe Non-Drug-Eluting Devices Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Non-Drug-Eluting Devices Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Non-Drug-Eluting Devices Sales Market Share in Value by Application in 2025 Figure 35. Latin America Non-Drug-Eluting Devices Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Non-Drug-Eluting Devices Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Non-Drug-Eluting Devices Sales Market Share in Value by Application in 2025 Figure 39. North America Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Non-Drug-Eluting Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Non-Drug-Eluting Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Non-Drug-Eluting Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Non-Drug-Eluting Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Non-Drug-Eluting Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Non-Drug-Eluting Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Non-Drug-Eluting Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Non-Drug-Eluting Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Non-Drug-Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Non-Drug-Eluting Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Non-Drug-Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Non-Drug-Eluting Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Non-Drug-Eluting Devices Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Non-Drug-Eluting Devices Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Implants
  • Sutures
Applications
  • Hospital
  • Ambulatory Surgical Centers
Companies covered
  • Teleflex Incorporated
  • Johnson & Johnson
  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Stryker Corporation
  • Smith & Nephew plc.
  • Peter Surgical
  • Integra Lifesciences
  • DemeTECH Corporation
  • ConMed Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Drug-Eluting Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Non-Drug-Eluting Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Non-Drug-Eluting Devices Market by Type
  6. 1.3.1 Implants
  7. 1.3.2 Sutures
  8. 1.4 Global Non-Drug-Eluting Devices Market Size by Type
  9. 1.4.1 Global Non-Drug-Eluting Devices Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Non-Drug-Eluting Devices Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Non-Drug-Eluting Devices Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Non-Drug-Eluting Devices Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Non-Drug-Eluting Devices Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Non-Drug-Eluting Devices Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Non-Drug-Eluting Devices Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Non-Drug-Eluting Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Non-Drug-Eluting Devices Industry Trends
  2. 2.2 Non-Drug-Eluting Devices Industry Drivers
  3. 2.3 Non-Drug-Eluting Devices Industry Opportunities and Challenges
  4. 2.4 Non-Drug-Eluting Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Non-Drug-Eluting Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Non-Drug-Eluting Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Non-Drug-Eluting Devices Price (2021-2026)
  4. 3.4 Global Non-Drug-Eluting Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-Drug-Eluting Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Non-Drug-Eluting Devices Company, Product Type & Application
  7. 3.7 Global Non-Drug-Eluting Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-Drug-Eluting Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-Drug-Eluting Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-Drug-Eluting Devices Tier 1, Tier 2, and Tier 3
4 Non-Drug-Eluting Devices Regional Status and Outlook
  1. 4.1 Global Non-Drug-Eluting Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Non-Drug-Eluting Devices Historic Market Size by Region
  3. 4.2.1 Global Non-Drug-Eluting Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Non-Drug-Eluting Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Non-Drug-Eluting Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Non-Drug-Eluting Devices Forecasted Market Size by Region
  7. 4.3.1 Global Non-Drug-Eluting Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Non-Drug-Eluting Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Non-Drug-Eluting Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-Drug-Eluting Devices by Application
  1. 5.1 Non-Drug-Eluting Devices Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.2 Global Non-Drug-Eluting Devices Market Size by Application
  5. 5.2.1 Global Non-Drug-Eluting Devices Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Non-Drug-Eluting Devices Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Non-Drug-Eluting Devices Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Non-Drug-Eluting Devices Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Non-Drug-Eluting Devices Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Non-Drug-Eluting Devices Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Non-Drug-Eluting Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Non-Drug-Eluting Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teleflex Incorporated
  2. 6.1.1 Teleflex Incorporated Company Information
  3. 6.1.2 Teleflex Incorporated Business Overview
  4. 6.1.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
  6. 6.1.5 Teleflex Incorporated Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Medtronic
  14. 6.3.1 Medtronic Company Information
  15. 6.3.2 Medtronic Business Overview
  16. 6.3.3 Medtronic Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
  18. 6.3.5 Medtronic Recent Developments
  19. 6.4 Boston Scientific Corporation
  20. 6.4.1 Boston Scientific Corporation Company Information
  21. 6.4.2 Boston Scientific Corporation Business Overview
  22. 6.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
  24. 6.4.5 Boston Scientific Corporation Recent Developments
  25. 6.5 B. Braun Melsungen AG
  26. 6.5.1 B. Braun Melsungen AG Company Information
  27. 6.5.2 B. Braun Melsungen AG Business Overview
  28. 6.5.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
  30. 6.5.5 B. Braun Melsungen AG Recent Developments
  31. 6.6 Stryker Corporation
  32. 6.6.1 Stryker Corporation Company Information
  33. 6.6.2 Stryker Corporation Business Overview
  34. 6.6.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
  36. 6.6.5 Stryker Corporation Recent Developments
  37. 6.7 Smith & Nephew plc.
  38. 6.7.1 Smith & Nephew plc. Company Information
  39. 6.7.2 Smith & Nephew plc. Business Overview
  40. 6.7.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
  42. 6.7.5 Smith & Nephew plc. Recent Developments
  43. 6.8 Peter Surgical
  44. 6.8.1 Peter Surgical Company Information
  45. 6.8.2 Peter Surgical Business Overview
  46. 6.8.3 Peter Surgical Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
  48. 6.8.5 Peter Surgical Recent Developments
  49. 6.9 Integra Lifesciences
  50. 6.9.1 Integra Lifesciences Company Information
  51. 6.9.2 Integra Lifesciences Business Overview
  52. 6.9.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
  54. 6.9.5 Integra Lifesciences Recent Developments
  55. 6.10 DemeTECH Corporation
  56. 6.10.1 DemeTECH Corporation Company Information
  57. 6.10.2 DemeTECH Corporation Business Overview
  58. 6.10.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
  60. 6.10.5 DemeTECH Corporation Recent Developments
  61. 6.11 ConMed Corporation
  62. 6.11.1 ConMed Corporation Company Information
  63. 6.11.2 ConMed Corporation Business Overview
  64. 6.11.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
  66. 6.11.5 ConMed Corporation Recent Developments
7 North America by Country
  1. 7.1 North America Non-Drug-Eluting Devices Sales by Country
  2. 7.1.1 North America Non-Drug-Eluting Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Non-Drug-Eluting Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Non-Drug-Eluting Devices Market Size by Country
  6. 7.2.1 North America Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Non-Drug-Eluting Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Non-Drug-Eluting Devices Sales by Country
  2. 8.1.1 Europe Non-Drug-Eluting Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Non-Drug-Eluting Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Non-Drug-Eluting Devices Market Size by Country
  6. 8.2.1 Europe Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Non-Drug-Eluting Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Non-Drug-Eluting Devices Sales by Country
  2. 9.1.1 Asia-Pacific Non-Drug-Eluting Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Non-Drug-Eluting Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Non-Drug-Eluting Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Non-Drug-Eluting Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Non-Drug-Eluting Devices Sales by Country
  2. 10.1.1 South America Non-Drug-Eluting Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Non-Drug-Eluting Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Non-Drug-Eluting Devices Market Size by Country
  6. 10.2.1 South America Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Non-Drug-Eluting Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Non-Drug-Eluting Devices Sales by Country
  2. 11.1.1 Middle East and Africa Non-Drug-Eluting Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Non-Drug-Eluting Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Non-Drug-Eluting Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Non-Drug-Eluting Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Non-Drug-Eluting Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Non-Drug-Eluting Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Non-Drug-Eluting Devices Value Chain Analysis
  2. 12.1.1 Non-Drug-Eluting Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Non-Drug-Eluting Devices Production Mode & Process
  7. 12.2 Non-Drug-Eluting Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Non-Drug-Eluting Devices Distributors
  10. 12.2.3 Non-Drug-Eluting Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst